AI-based liquid biopsy may detect liver fibrosis, cirrhosis, and broader chronic disease signals, Johns Hopkins researchers find

Vasan Yegnasubramanian: How AI is transforming cancer research and treatment

Vasan Yegnasubramanian, MD, PhD, is the director of Precision inHealth Medicine at Johns Hopkins. He spoke with Johns Hopkins Kimmel Cancer Center communications staff about how AI is transforming cancer research and treatment. The transcript of the conversation follows.

March 06, 2026

Vol.52 No.09

By John’s Hopkins Kimmel Cancer Center Communications

Clinical Roundup

Johns Hopkins investigators create open source database to more easily study cancer data

Researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University have created a novel database structure that allows investigators anywhere to more easily study multiple types of cancer data—including laboratory results, genetic sequencing and imaging data—in one setting.

March 06, 2026

Vol.52 No.09

Podcast

Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era

Two lawsuits filed within days of each other in the U.S. District Court for the Northern District of Illinois claimed that Tempus AI Inc., an AI-driven precision and genomic testing company, had violated the Illinois Genetic Information Privacy Act when it acquired Ambry Genetics and started to integrate its genetics data into its predictive models.

March 04, 2026

Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE
“Deidentified” ≠ “deidentifiable”

Two lawsuits filed within days of each other in the U.S. District Court for the Northern District of Illinois claim that Tempus AI Inc. had violated the Illinois Genetic Information Privacy Act when it acquired Ambry Genetics and started to integrate its genetics data into its predictive models.

February 27, 2026

Vol.52 No.08

By Paul Goldberg

Black History Month Podcast

Malcolm V. Brock on his journey from Bermuda to Japan to the U.S. to England–and from Japanese studies to thoracic oncology
“When it gets down to brass tacks, relationships between each other, we’re all one.”

Malcolm V. Brock, director of Clinical and Translational Research in Thoracic Surgery at Johns Hopkins Kimmel Comprehensive Cancer Center, grew up in Bermuda. His father insisted that his children branch outside the small island—the country has a population of just over 60,000 people—and challenge themselves abroad.

February 20, 2026

Vol.52 No.07

By Malcolm V. Brock, Robert A. Winn and Preston Willett

Clinical Roundup

Exposure to pathogenic bacteria significantly increased SMOX activity, leading growth and metastasis of breast cancer, JHU-led study finds

Researchers at the Johns Hopkins Kimmel Cancer Center have discovered how certain pathogenic bacteria in gut and breast tissue can promote breast cancer development and progression by hijacking a key metabolic enzyme known as spermine oxidase.

February 20, 2026

Vol.52 No.07

AI-based liquid biopsy may detect liver fibrosis, cirrhosis, and broader chronic disease signals, Johns Hopkins researchers find

YOU MAY BE INTERESTED IN

Vasan Yegnasubramanian: How AI is transforming cancer research and treatment

Johns Hopkins investigators create open source database to more easily study cancer data

Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era

Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE
“Deidentified” ≠ “deidentifiable”

Malcolm V. Brock on his journey from Bermuda to Japan to the U.S. to England–and from Japanese studies to thoracic oncology
“When it gets down to brass tacks, relationships between each other, we’re all one.”

Exposure to pathogenic bacteria significantly increased SMOX activity, leading growth and metastasis of breast cancer, JHU-led study finds

Renew today!

Subscriber content

Never miss an issue!

Login

AI-based liquid biopsy may detect liver fibrosis, cirrhosis, and broader chronic disease signals, Johns Hopkins researchers find

YOU MAY BE INTERESTED IN

Vasan Yegnasubramanian: How AI is transforming cancer research and treatment

Johns Hopkins investigators create open source database to more easily study cancer data

Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era

Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE“Deidentified” ≠ “deidentifiable”

Malcolm V. Brock on his journey from Bermuda to Japan to the U.S. to England–and from Japanese studies to thoracic oncology“When it gets down to brass tacks, relationships between each other, we’re all one.”

Exposure to pathogenic bacteria significantly increased SMOX activity, leading growth and metastasis of breast cancer, JHU-led study finds

Never miss an issue!

Login

Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE
“Deidentified” ≠ “deidentifiable”

Malcolm V. Brock on his journey from Bermuda to Japan to the U.S. to England–and from Japanese studies to thoracic oncology
“When it gets down to brass tacks, relationships between each other, we’re all one.”